BackNew Covid strain likely to be more dangerous, says report
The study which used Covid samples over six months indicated that a new variant could cause more illness than the current predominant omicron strain
PremiumA recent South African laboratory study using Covid-19 samples from an immunosuppressed individual has showed that the virus evolved to become more pathogenic, Sigal Labs said on 26 November.
The study, that used Covid-19 samples over six months, indicated that a new variant could cause more illness than the current predominant omicron strain.
Last year, the same South African laboratory was to first test the omicron strain against vaccines. It now has used samples from a person infected with HIV.
In the past 6 months, the virus initially caused the same level of cell fusion and death as the omicron BA.1 strain, but as it evolved those levels rose to become similar to the first version of Covid-19 identified in Wuhan in China.
ALSO READ: Covid-19 isn't slowing down in China. What it means for India
Led by Alex Sigal at the Africa Health Research Institute in the South African city of Durban, the study indicated that the Covid-19 pathogen could continue to mutate and a new variant may cause more severe illness and death than the relatively mild omicron strain.
However, the study is yet to be peer reviewed and is based solely on laboratory work on samples from one individual.
Previously, Sigal and other scientists have postulated that variants such as beta and omicron -- both initially identified in southern Africa -- may have evolved in immunosuppressed people such as those infected with HIV.
The long time it takes for these individuals to shake off the disease allows it to mutate and become better at evading antibodies, the researchers have said.
"The study may indicate that SARS-CoV-2 evolution in long-term infection does not have to result in attenuation," the researchers said in their findings, which were released on Nov. 24.
“It may indicate that a future variant could be more pathogenic than currently circulating Omicron strains," it added.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!
